登录    
  
首页 > 期刊论文 > 论文摘要
基于质谱鉴定的肝癌标志物的血清iTRAQ分析
         
iTRAQ analysis of serum biomarkers of hepatocellular carcinoma based on mass spectrometry

摘    要
目的:采用核素标记相对和绝对定量(isobaric tags for relative and absolute quantitation,iTRAQ)技术分析已报道的基于质谱鉴定的肝癌标志物在血清中的表达水平。方法:通过PubMed查阅2003年1月-2010年8月发表的,采用差异蛋白筛选结合基质辅助激光解析/电离-飞行时间质谱技术(matrix-assisted laser desorption/ionization time-of-fight mass spectrometry,MALDI-TOF-MS)鉴定的有关肝癌生物标志物的文献;同时运用iTRAQ标记技术结合MALDI-TOF-MS串联质谱技术,对20例肝癌患者与20例健康对照的血清进行差异蛋白组学分析。将文献报道的肝癌标志物数据与肝癌血清差异蛋白组学数据进行比对。结果:通过文献检索共获得符合要求的文献22篇,涉及肝癌相关标志物262个。肝癌血清差异蛋白组筛选出表达有显著差异的蛋白51个,其中在肝癌血清中高表达差异蛋白23个,低表达差异蛋白28个;与文献报道吻合的标志物8个,其中与文献报道表达水平一致的差异蛋白为6个[α-1-抗胰蛋白酶(alpha-1-antitrypsin,AAT)、载脂蛋白E(apolipoprotein E,APOE)、蛋白血浆铜蓝蛋白(ceruloplasmin,CP)、甲胎蛋白(alpha fetoprotein,AFP)、补体C3(complement C3,C3)和血清淀粉状蛋白P片段(serum amyloid P-component,APCS)]。结论:血清中鉴定获得的6个与文献报道一致的差异蛋白可能是潜在肝癌标志物,值得进一步深入探讨研究。
标    签 肝肿瘤   生物标志物   核素标记   串联质谱   Liver neoplasms   Biomarkers   Isotope labeling   Tandem mass spectrometry  
 
Abstract
Objective:The technique of isobaric tags for relative and absolute quantitation(iTRAQ) was used to analyze the expression levels of serum biomarkers of hepatocellular carcinoma(HCC) based on mass spectrometry.Methods:The literature about HCC biomarkers identified by screening of differential protein expression combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry(MALDI-TOF-MS) published between January 2003 and August 2010 were selected by searching PubMed database.Screening for serum differential proteins was performed in 20 HCC patients and 20 healthy volunteers by using iTRAQ labeling and MALDI-TOF-MS.The reported data of HCC biomarkers were compared with the screening results of serum differential protein expression in HCC.Results:Twenty-two pieces of eligible literature were obtained by information retrieval,involving 262 HCC biomarkers.Fifty-one proteins were identified having differential expression by using screening of serum differential protein expression in HCC.In the 51 proteins,the expression level of 23 proteins was high,while the expression level of 28 proteins was low.Eight differential proteins which were identified by screening,were in accordance with literature reports,and 6 differential proteins(alpha-1-antitrypsin,apolipoprotein E,ceruloplasmin,alpha fetoprotein,complement C3 and serum amyloid P-component) had the similar expression levels in accordance with literature reports.Conclusion:Six differential proteins identified in serum are the same as reported in the literatures,and these proteins may become potential HCC biomarkers.There is a need for further study to explore these differential proteins.

中图分类号 R735.7   DOI 10.3781/j.issn.1000-7431.2011.07.012

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 临床研究

基金项目 国家自然科学基金资助项目(编号:30960332);广西科学研究与技术开发计划项目(编号:桂科能05112001-4A,0630006-5E,0842009)

收稿日期 2010/12/6

修改稿日期 2011/3/28

网络出版日期

作者单位点击查看


引用该论文: ZHANG Qin-le,YANG Xiao-li,LI Gang,HE Xiao,ZANG Ning,HU Yan-ling,ZHANG Xue-rong,HE Min. iTRAQ analysis of serum biomarkers of hepatocellular carcinoma based on mass spectrometry[J]. Tumor, 2011, 31(7): 638~643
张钦乐,杨小丽,李刚,何晓,臧宁,胡艳玲,张学荣,何敏. 基于质谱鉴定的肝癌标志物的血清iTRAQ分析[J]. 肿瘤, 2011, 31(7): 638~643


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】YOON S K. Recent advances in tumor marker of human hepatocellular carcinoma[J]. Intervirology, 2008, 51(Suppl 1):34-41.
 
【2】YOON S K. Recent advances in tumor marker of human hepatocellular carcinoma[J]. Intervirology, 2008, 51(Suppl 1):34-41.
 
【3】王维林, 白 鑫, 屠 红. 肝癌血清标志物研究的新进展[J]. 肿瘤, 2009, 29(4):389-393.
 
【4】王维林, 白 鑫, 屠 红. 肝癌血清标志物研究的新进展[J]. 肿瘤, 2009, 29(4):389-393.
 
【5】中国抗癌协会肝癌专业委员会. 原发性肝癌的临床诊断与分析标准[J]. 中华肝脏病杂志, 2001, 9(6):321.
 
【6】中国抗癌协会肝癌专业委员会. 原发性肝癌的临床诊断与分析标准[J]. 中华肝脏病杂志, 2001, 9(6):321.
 
【7】NA K, LEE E Y, LEE H J, et al. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma[J]. Proteomics, 2009, 9(16):3989-3999.
 
【8】NA K, LEE E Y, LEE H J, et al. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma[J]. Proteomics, 2009, 9(16):3989-3999.
 
【9】ZHANG D H, LIM S G, KOAY E S, et al. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma[J]. Int J Oncol, 2007, 31(3):577-584.
 
【10】ZHANG D H, LIM S G, KOAY E S, et al. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma[J]. Int J Oncol, 2007, 31(3):577-584.
 
【11】FUJII K, KONDO T, YOKOO H, et al. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye[J]. Proteomics, 2005, 5(5):1411-1422.
 
【12】FUJII K, KONDO T, YOKOO H, et al. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye[J]. Proteomics, 2005, 5(5):1411-1422.
 
【13】QIU J G, FAN J, LIU Y K, et al. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma[J]. Cancer Res Clin Oncol, 2008, 134(3):299-305.
 
【14】QIU J G, FAN J, LIU Y K, et al. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma[J]. Cancer Res Clin Oncol, 2008, 134(3):299-305.
 
【15】FENG J T, LIU Y K, SONG H Y, et al. Heat-shock protein 27:A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis[J]. Proteomics, 2005, 5(17):4581-4588.
 
【16】FENG J T, LIU Y K, SONG H Y, et al. Heat-shock protein 27:A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis[J]. Proteomics, 2005, 5(17):4581-4588.
 
【17】LI C, TAN Y X, ZHOU H, et al. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma:Identification of potential tumor markers[J]. Proteomics, 2005, 5(4):1125-1139.
 
【18】LI C, TAN Y X, ZHOU H, et al. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma:Identification of potential tumor markers[J]. Proteomics, 2005, 5(4):1125-1139.
 
【19】SUN W, XING B C, SUN Y, et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis-novel protein markers in hepatocellular carcinoma tissues[J]. Mol Cell Proteomics, 2007, 6(10):1798-1808.
 
【20】SUN W, XING B C, SUN Y, et al. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis-novel protein markers in hepatocellular carcinoma tissues[J]. Mol Cell Proteomics, 2007, 6(10):1798-1808.
 
【21】MELLE C, ERNST G, SCHEIBNER O, et al. Identification of specific protein markers in microdissected hepatocellular carcinoma[J]. J Proteome Res, 2007, 6(1):306-315.
 
【22】MELLE C, ERNST G, SCHEIBNER O, et al. Identification of specific protein markers in microdissected hepatocellular carcinoma[J]. J Proteome Res, 2007, 6(1):306-315.
 
【23】YI X, LUK J M, LEE N P, et al. Association of mortalin (hspa9) with liver cancer metastasis and prediction for early tumor recurrence[J]. Mol Cell Proteomics, 2008, 7(2):315-325.
 
【24】YI X, LUK J M, LEE N P, et al. Association of mortalin (hspa9) with liver cancer metastasis and prediction for early tumor recurrence[J]. Mol Cell Proteomics, 2008, 7(2):315-325.
 
【25】ZEINDL-EBERHART E, HARAIDA S, LIEBMANN S, et al. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas[J]. Hepatology, 2004, 39(2):540-549.
 
【26】ZEINDL-EBERHART E, HARAIDA S, LIEBMANN S, et al. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas[J]. Hepatology, 2004, 39(2):540-549.
 
【27】PARK K S, KIM H, KIN N G, et al. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma[J]. Heatology, 2002, 35(6):1459-1466.
 
【28】PARK K S, KIM H, KIN N G, et al. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma[J]. Heatology, 2002, 35(6):1459-1466.
 
【29】ZUBAIDAH R M, TAN G S, TAN S B, et al. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenes[J]. Proteomics, 2008, 8(23-24):5086-5096.
 
【30】ZUBAIDAH R M, TAN G S, TAN S B, et al. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenes[J]. Proteomics, 2008, 8(23-24):5086-5096.
 
【31】STELL L F, SHUMPERT D, TROTTER M, et al. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma[J]. Proteomics, 2003, 3(5):601-609.
 
【32】STELL L F, SHUMPERT D, TROTTER M, et al. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma[J]. Proteomics, 2003, 3(5):601-609.
 
【33】XU Z B, ZHOU X W, LU H J, et al. Comparative glycoproteomics based on lectins affinity capture of N-linked glycoproteins from human Chang liver cells and MHCC97-H cells[J]. Proteomics, 2007, 7(14):2358-2370.
 
【34】XU Z B, ZHOU X W, LU H J, et al. Comparative glycoproteomics based on lectins affinity capture of N-linked glycoproteins from human Chang liver cells and MHCC97-H cells[J]. Proteomics, 2007, 7(14):2358-2370.
 
【35】BLANC J F, LALANNE C, PLOMION C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C[J]. Proteomics, 2005, 5(14):3778-3789.
 
【36】BLANC J F, LALANNE C, PLOMION C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C[J]. Proteomics, 2005, 5(14):3778-3789.
 
【37】TAKASHIMA M, KURAMITSU Y, YOKOYAMA Y, et al. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma[J]. Proteomics, 2003, 3(12):2487-2493.
 
【38】TAKASHIMA M, KURAMITSU Y, YOKOYAMA Y, et al. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma[J]. Proteomics, 2003, 3(12):2487-2493.
 
【39】LUK J M, LAM C T, SIU A F, et al. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values[J]. Proteomics, 2006, 6(3):1049-1057.
 
【40】LUK J M, LAM C T, SIU A F, et al. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values[J]. Proteomics, 2006, 6(3):1049-1057.
 
【41】YOKOYAMA Y, KURAMITSU Y, TAKASHIMA M, et al. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus[J]. Proteomics, 2004, 4(7):2111-2116.
 
【42】YOKOYAMA Y, KURAMITSU Y, TAKASHIMA M, et al. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus[J]. Proteomics, 2004, 4(7):2111-2116.
 
【43】LEE N P, CHEN L, LIN M C, et al. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma[J]. J Proteome Res, 2009, 8(3):1293-1303.
 
【44】LEE N P, CHEN L, LIN M C, et al. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma[J]. J Proteome Res, 2009, 8(3):1293-1303.
 
【45】CODARIN E, RENZONE G, POZ A, et al. Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues[J]. J Proteome Res, 2009, 8(5):2273-2284.
 
【46】CODARIN E, RENZONE G, POZ A, et al. Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues[J]. J Proteome Res, 2009, 8(5):2273-2284.
 
【47】LI N, LONG Y Z, FAN X G, et al. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues[J]. J Exp Clin Cancer Res, 2009, 8, 28:122.
 
【48】LI N, LONG Y Z, FAN X G, et al. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues[J]. J Exp Clin Cancer Res, 2009, 8, 28:122.
 
【49】SUN S, XU M Z, POON R T, et al. Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients[J]. J Proteome Res, 2010, 9(1):70-78.
 
【50】SUN S, XU M Z, POON R T, et al. Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients[J]. J Proteome Res, 2010, 9(1):70-78.
 
【51】王林纤, 戴 勇, 涂植光. iTRAQ标记技术与差异蛋白质组学的生物标志物研究[J]. 生命的化学, 2010, 30(1):135-140.
 
【52】王林纤, 戴 勇, 涂植光. iTRAQ标记技术与差异蛋白质组学的生物标志物研究[J]. 生命的化学, 2010, 30(1):135-140.
 
【53】HONG W S, HONG S I. Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma[J]. J Korean Med Sci, 1991, 6(3):206-213.
 
【54】HONG W S, HONG S I. Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma[J]. J Korean Med Sci, 1991, 6(3):206-213.
 
【55】CHIO L F, OON C J. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma[J]. Cancer, 1979, 43(2):596-604.
 
【56】CHIO L F, OON C J. Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma[J]. Cancer, 1979, 43(2):596-604.
 
【57】POUSSET D, PILLER V, BUREAUD N, et al. High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma[J]. Eur J Biochem, 2001, 268(5):1491-1499.
 
【58】POUSSET D, PILLER V, BUREAUD N, et al. High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma[J]. Eur J Biochem, 2001, 268(5):1491-1499.
 
【59】SENRA VAREAL A, LOPEZ SAEZ J J, QUINTELA SENRA D, et al. Serum ceruloplasmin as a diagnostic marker of cancer[J]. Cancer Lett, 1997, 121(2):139-145.
 
【60】SENRA VAREAL A, LOPEZ SAEZ J J, QUINTELA SENRA D, et al. Serum ceruloplasmin as a diagnostic marker of cancer[J]. Cancer Lett, 1997, 121(2):139-145.
 
【61】SUN S, LEE N P, POON R T, et al. Oncoproteomics of hepatocellular carcinoma:from cancer markers discovery to functional pathways[J]. Liver Int, 2007, 27(8):1021-1038.
 
【62】SUN S, LEE N P, POON R T, et al. Oncoproteomics of hepatocellular carcinoma:from cancer markers discovery to functional pathways[J]. Liver Int, 2007, 27(8):1021-1038.
 
【63】BJØRGE L, HAKULINEN J, VINTERMYR O K, et al. Ascitic complement system in ovarian cancer[J]. Br J Cancer, 2005, 92(5):895-905.
 
【64】BJØRGE L, HAKULINEN J, VINTERMYR O K, et al. Ascitic complement system in ovarian cancer[J]. Br J Cancer, 2005, 92(5):895-905.
 
相关信息
   标题 相关频次
 EPHX 1基因多态性与原发性肝癌易感性的关系
 2
 MDR1基因表达与肝癌患者TACE治疗反应性及预后的关系
 2
 PEG10基因在肝癌组织中高表达的分子机制及其功能的研究
 2
 TC21/R-Ras2在肝癌中的表达、亚细胞定位及意义
 2
 125I粒子组织间植入治疗荷瘤裸鼠移植性肝癌
 2
 188Re-HAb18F(ab')2肝癌放射免疫显像的研究
 2
 2(3)-叔丁基-4-羟基茴香醚对HBV转基因小鼠肝肿瘤的防护作用研究
 2
 AFP启动子调控PNP载体的构建及分析
 2
 AHR小干扰RNA对肝癌HCCLM3细胞体外增殖和体内肿瘤生长的影响
 2
 As2O3联合AZT通过激活caspase-3通路抑制肝癌HepG2细胞的增殖
 2
 As2O3联合AZT作用对肝癌HepG2细胞迁移和侵袭的影响
 2
 Bevacizumab抑制高转移性人肝癌原位移植瘤的淋巴管形成
 2
 CD44v6 mRNA在原发性肝癌患者外周血中检测的临床意义
 2
 CDK抑制剂BMS-265246体外诱导肝癌细胞周期阻滞和细胞凋亡
 2
 CL-L 1基因在肝癌中的表达及其功能研究
 2
 CT引导射频消融治疗膈顶部肝癌的临床研究
 2
 DCs-CIK联合TACE治疗原发性肝癌的研究
 2
 DNA甲基化抑制剂5-氮杂-2'-脱氧胞苷抗癌新机制初探
 2
 HBsAg携带者补硒后影响肝癌发生的实验流行病学研究
 2
 HBV/HCV相关性肝细胞癌抗病毒治疗专家建议
 2
 HCPT诱导肝癌细胞凋亡时AIF定位变化与DNA的损伤
 2
 HIFU治疗肝脏恶性肿瘤的临床观察
 2
 HSV-TK/CD基因联合IL-12基因体内治疗肝癌
 2
 JNK通路介导人肝癌耐药细胞株Bel-7402/FU多药耐药的调控机制
 2
 MicroRNA与DNA甲基化相互调节机制在肝细胞癌中的研究进展
 2
 MiR-21通过AKT/ERK途径对肝癌BEL-7402细胞增殖和迁移的影响
 2
 NS-398对肝癌SMMC7721和BEL-7402细胞凋亡和survivin、PTEN表达调节作用的研究
 2
 PEG10基因在肝癌组织中高表达的分子机制及其功能的研究
 2
 PNP/MeP-dR系统对肝癌细胞杀伤作用的实验研究
 2
 POKemon和NF-κB p65在肝癌细胞中的信号调控
 2

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2